Eplontersen
ION-682884-CS2
Phase 3 small_molecule active
Quick answer
Eplontersen for Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) is a Phase 3 program (small_molecule) at IONIS PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- IONIS PHARMACEUTICALS INC
- Indication
- Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active